Figure 2
PCR-SSP genotyping. Refer to Table 2 for information on each primer mix. (a) KIR genotyping of two Epstein–Barr virus-transformed lymphoblastoid cell lines from the 10th International Histocompatibility Workshop. Sample 1 (S1 on figure), MZ070782, is positive for the following KIR: KIR2DL1, -2DL2, -2DL4, -2DL5, -2DS1, -2DS2, -2DS3, -2DS4, -2DS5, -3DL1, -3DL2, -3DL3 and -3DS1; Sample 2 (S2), JBUSH: KIR2DL1, -2DL3, -2DL4, -2DS4, -3DL1, -3DL2, and -3DL3. (b) Results of HLA-KIR ligand genotyping of two control samples. S1 is positive for the HLA-Cw epitopes C2 and C1. S2 is homozygous for the HLA-Cw epitope C2. (c) Results of NKG2D SNP typing of two control samples. S1 is heterozygous for Thr72 and Ala72; S2 is homozygous for Thr72.
